subscribeSubscribe
XCOPRI® Approved For Alternate Oral, Nasogastric Tube Use

XCOPRI® Approved For Alternate Oral, Nasogastric Tube Use
PR NEWSWIRE
11 Apr 2024
Share Share
SK Life: XCOPRI® Data At AAN 2024

SK Life: XCOPRI® Data At AAN 2024
PR NEWSWIRE
09 Apr 2024
Share Share
SK Life Science touts epilepsy support programs for Purple Day

SK Life Science touts epilepsy support programs for Purple Day
Andrea Park FIERCE PHARMA
25 Mar 2024
Share Share
Endo Announces Approval of XCOPRI (cenobamate tablets) in Canada

Endo Announces Approval of XCOPRI (cenobamate tablets) in Canada
PR NEWSWIRE
30 Jun 2023
Share Share
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada

Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
PR NEWSWIRE
29 Jun 2023
Share Share
Approval provided for Angelini’s cenobamate

Approval provided for Angelini’s cenobamate
PHARMATIMES
16 May 2023
Share Share
Latest XCOPRI® (cenobamate tablets) CV Post-hoc Analysis Presented at the ANN

Latest XCOPRI® (cenobamate tablets) CV Post-hoc Analysis Presented at the ANN
PR NEWSWIRE
17 Apr 2023
Share Share
Cenobamate is Now Available in France and Belgium

Cenobamate is Now Available in France and Belgium
BUSINESSWIRE
07 Dec 2022
Share Share
SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV

SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV
PRNEWSWIRE
02 Dec 2022
Share Share
SK life science To Present Latest XCOPRI® (cenobamate tablets) CV Data

SK life science To Present Latest XCOPRI® (cenobamate tablets) CV Data
PRNEWSWIRE
28 Nov 2022
Share Share